Results 21 - 30 of 50 : Previous 1 2 3 4 5 Next
Anthera starts its phase 3 program for blisibimod.
Finding companies that have all the right stuff can produce winners.
Is Complete Genomics the Perfect Penny Stock?
A low price doesn't always mean low quality.
The notable moves and news of the day.
2 Biotechs Trouncing the Market
These stocks had outsized moves.
These stocks sank like rocks.
Making a Multibagger: Behind the Decade's Best Stocks
It's not easy to identify exceptional companies before they take off, but the Fool can help.
Invest Better: It's OK to Not Understand
Sometimes, passing on a stock is the best option.
Three indicators investors should look for in order to find market-crushing stocks.
5-Star Stocks Poised to Pop: ChemoCentryx
Market-trouncing returns could be written in these stars.